Australasian Gastro-Intestinal Trials Group (AGITG)

The Australasian Gastro-Intestinal Trials Group (AGITG) incorporated as a Company Limited by Guarantee in 2000 and now encompasses a wide range of medical specialists, scientists, nurses, allied health professionals and consumers. The GI Cancer Institute is the community division of the AGITG, working across Australia to raise funds and awareness of GI cancer and clinical trials.

Since 1991, They have been committed to changing outcomes for people with gastro-intestinal (GI) cancer. Their key priority is to undertake research to improve patient care and medical practice. The 60 clinical trials conducted by the AGITG, since the group was first formed as a network of investigators, have involved over 7,000 participants treated at 115 sites in Australia, 8 sites in New Zealand and 110 sites located across Asia, Europe, North America and the Middle East.

Mission:
They put patients with gastro-intestinal cancer at the centre of Their research, saving and improving lives by accelerating the pace of discoveries that lead to cures.

Their dedicated group of research and health professionals translate bold new ideas in to life-saving clinical trials that help those patients as quickly as possible.

VIsion:
To create a world free from gastro‐intestinal cancers.